Review



coda noninvasive tail cuff blood pressure measurement system  (Kent Scientific Corp)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Kent Scientific Corp coda noninvasive tail cuff blood pressure measurement system
    Coda Noninvasive Tail Cuff Blood Pressure Measurement System, supplied by Kent Scientific Corp, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/coda+noninvasive+tail+cuff+blood+pressure+system/blood+cuff+measurement+pressure+system+tail/pm41485517-78-1-8
    Average 86 stars, based on 1 article reviews
    coda noninvasive tail cuff blood pressure measurement system - by Bioz Stars, 2026-10
    86/100 stars

    Images

    Related Articles

    other:

    Article Title: In Vivo RNA Interference Models of Inducible and Reversible Sirt1 Knockdown in Kidney Cells
    Article Snippet: Blood pressure was measured by CODA noninvasive tail cuff blood pressure system (Kent Scientific, Torrington, CT).

    Article Title: Investigation of blood pressure regulatory effect of bioactive peptides in complex enzyme-assisted hydrolysate from Paralichthys olivaceus
    Article Snippet: This study aimed to identify the bioactive peptides of protamex-pepsin hydrolysate obtained from Paralichthys olivaceus (POppH) and to investigate their potential vasorelaxation and blood pressure regulatory properties, both in vitro and in vivo.. The effects of the peptides on endothelium-derived relaxing factors (EDRFs), such as nitric oxide and hydrogen sulfate levels, were analyzed in EA. hy926 cells, and the vasorelaxation-related PI3K/AKT/ eNOS pathway activity was analyzed in EA. hy926 cells.. An in vitro study revealed that POppH and leucineglutamic acid-arginine (IER) peptide did not show any cytotoxic effects and significantly increased EDRF production via the regulation of vasorelaxation-associated PI3K/AKT/eNOS protein expression in EA. hy926 cells.

    Article Title: BAMBI Elimination Enhances Alternative TGF-β Signaling and Glomerular Dysfunction in Diabetic Mice
    Article Snippet: Blood pressure was measured using the CODA noninvasive tail cuff blood pressure system (Kent Scientific, Torrington, CT) ( ).

    Article Title: In vivo RNA interference models of inducible and reversible Sirt1 knockdown in kidney cells.
    Article Snippet: Tail Cuff Noninvasive Blood Pressure Blood pressure was measured by CODA noninvasive tail cuff blood pressure system (Kent Scientific, Torrington, CT).

    Article Title: In Vivo RNA Interference Models of Inducible and Reversible Sirt1 Knockdown in Kidney Cells
    Article Snippet: Tail Cuff Noninvasive Blood Pressure Blood pressure was measured by CODA noninvasive tail cuff blood pressure system (Kent Scientific, Torrington, CT).



    Similar Products

    86
    Kent Scientific Corp coda noninvasive tail cuff blood pressure measurement system
    Coda Noninvasive Tail Cuff Blood Pressure Measurement System, supplied by Kent Scientific Corp, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/coda+noninvasive+tail+cuff+blood+pressure+system/blood+cuff+measurement+pressure+system+tail/pm41485517-78-1-8
    Average 86 stars, based on 1 article reviews
    coda noninvasive tail cuff blood pressure measurement system - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Kent Scientific Corp noninvasive computerized coda tail cuff blood pressure system
    a Experiment design. 16-week-old C57BL/6 J mice were infused with AngII (1000 ng/kg·min − 1 ) for 28 days. After 7 days of infusion, the mice were daily injected with vehicle, dihydropyridine CCBs [amlodipine (1 mg/kg/day) or nifedipine (20 mg/kg/day)], benzothiazepine CCB [diltiazem (8 mg/kg/day)], phenylalkylamine CCBs [verapamil (12 mg/kg/day)]. b SBP was measured <t>by</t> <t>tail-cuff</t> at −7, 0, 3, 7, 14, 21 days after vehicle/CCBs treatment. c –e Ultrasound-monitored maximal inner diameters of the aortic root, ascending aorta, and aortic arch at 0, 7, 14, 21 days. f Representative ultrasound images of thoracic aorta after 21 days of vehicle/CCB treatment. g –i Monitoring of rd-PWV and ascending aortic strain in mice at different time points by M-mode ultrasound. ( g ) Schematic illustration of calculation method. ( h ) rd-PWV. i Ascending aortic strain. j Representative ex vivo morphology of thoracic aortas. Scale bar=2 mm. k –m Maximal external diameters of ascending aorta ( k ), aortic arch ( l ), and descending aorta ( m ). Data presentation : Data in ( b –e, h , i, k-m ) are presented as mean ± SEM. For some points, SEM is smaller than the symbol size and not visually discernible. Each data point represents an individual mouse as a biological replicate with similar results. The initial sample sizes per group were: Saline + Vehicle ( n = 7), AngII + Vehicle ( n = 13), AngII + Amlodipine ( n = 12), AngII + Nifedipine ( n = 12), AngII + Diltiazem ( n = 11), AngII + Verapamil ( n = 11). Due to mortality during the experimental period, exact n at each time point is provided in the Source Data file. Statistical analysis : Two-sided one-way ANOVA with Dunnett multiple comparisons test, Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test or Kruskal-Wallis test with Dunn’s multiple comparisons was used as appropriate for ( b-e , h , i ) at different time points (detailed for each comparison in the Source Data file). * P < 0.05 vs. AngII + Vehicle group. Exact P -values for all comparisons are provided in the Source Data file. Statistical analysis of ( k –m ) were performed using two-sided Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test. Source data are provided as a Source Data file. AngII angiotensin II, SBP systolic blood pressure, CCB calcium channel blocker, rd-PWV root to descending aorta pulse wave velocity.
    Noninvasive Computerized Coda Tail Cuff Blood Pressure System, supplied by Kent Scientific Corp, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/coda+noninvasive+tail+cuff+blood+pressure+system/coda+system/pmc12873303-359-2-9
    Average 86 stars, based on 1 article reviews
    noninvasive computerized coda tail cuff blood pressure system - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    90
    Kent Scientific Corp noninvasive computerized tail-cuff iitc blood pressure system coda non-invasive blood pressure system
    a Experiment design. 16-week-old C57BL/6 J mice were infused with AngII (1000 ng/kg·min − 1 ) for 28 days. After 7 days of infusion, the mice were daily injected with vehicle, dihydropyridine CCBs [amlodipine (1 mg/kg/day) or nifedipine (20 mg/kg/day)], benzothiazepine CCB [diltiazem (8 mg/kg/day)], phenylalkylamine CCBs [verapamil (12 mg/kg/day)]. b SBP was measured <t>by</t> <t>tail-cuff</t> at −7, 0, 3, 7, 14, 21 days after vehicle/CCBs treatment. c –e Ultrasound-monitored maximal inner diameters of the aortic root, ascending aorta, and aortic arch at 0, 7, 14, 21 days. f Representative ultrasound images of thoracic aorta after 21 days of vehicle/CCB treatment. g –i Monitoring of rd-PWV and ascending aortic strain in mice at different time points by M-mode ultrasound. ( g ) Schematic illustration of calculation method. ( h ) rd-PWV. i Ascending aortic strain. j Representative ex vivo morphology of thoracic aortas. Scale bar=2 mm. k –m Maximal external diameters of ascending aorta ( k ), aortic arch ( l ), and descending aorta ( m ). Data presentation : Data in ( b –e, h , i, k-m ) are presented as mean ± SEM. For some points, SEM is smaller than the symbol size and not visually discernible. Each data point represents an individual mouse as a biological replicate with similar results. The initial sample sizes per group were: Saline + Vehicle ( n = 7), AngII + Vehicle ( n = 13), AngII + Amlodipine ( n = 12), AngII + Nifedipine ( n = 12), AngII + Diltiazem ( n = 11), AngII + Verapamil ( n = 11). Due to mortality during the experimental period, exact n at each time point is provided in the Source Data file. Statistical analysis : Two-sided one-way ANOVA with Dunnett multiple comparisons test, Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test or Kruskal-Wallis test with Dunn’s multiple comparisons was used as appropriate for ( b-e , h , i ) at different time points (detailed for each comparison in the Source Data file). * P < 0.05 vs. AngII + Vehicle group. Exact P -values for all comparisons are provided in the Source Data file. Statistical analysis of ( k –m ) were performed using two-sided Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test. Source data are provided as a Source Data file. AngII angiotensin II, SBP systolic blood pressure, CCB calcium channel blocker, rd-PWV root to descending aorta pulse wave velocity.
    Noninvasive Computerized Tail Cuff Iitc Blood Pressure System Coda Non Invasive Blood Pressure System, supplied by Kent Scientific Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/coda+noninvasive+tail+cuff+blood+pressure+system/coda+non+invasive+blood+pressure+system/10__3390_slash_antiox14030266-83-13-25
    Average 90 stars, based on 1 article reviews
    noninvasive computerized tail-cuff iitc blood pressure system coda non-invasive blood pressure system - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Kent Scientific Corp noninvasive tail-cuff blood pressure system coda
    a Experiment design. 16-week-old C57BL/6 J mice were infused with AngII (1000 ng/kg·min − 1 ) for 28 days. After 7 days of infusion, the mice were daily injected with vehicle, dihydropyridine CCBs [amlodipine (1 mg/kg/day) or nifedipine (20 mg/kg/day)], benzothiazepine CCB [diltiazem (8 mg/kg/day)], phenylalkylamine CCBs [verapamil (12 mg/kg/day)]. b SBP was measured <t>by</t> <t>tail-cuff</t> at −7, 0, 3, 7, 14, 21 days after vehicle/CCBs treatment. c –e Ultrasound-monitored maximal inner diameters of the aortic root, ascending aorta, and aortic arch at 0, 7, 14, 21 days. f Representative ultrasound images of thoracic aorta after 21 days of vehicle/CCB treatment. g –i Monitoring of rd-PWV and ascending aortic strain in mice at different time points by M-mode ultrasound. ( g ) Schematic illustration of calculation method. ( h ) rd-PWV. i Ascending aortic strain. j Representative ex vivo morphology of thoracic aortas. Scale bar=2 mm. k –m Maximal external diameters of ascending aorta ( k ), aortic arch ( l ), and descending aorta ( m ). Data presentation : Data in ( b –e, h , i, k-m ) are presented as mean ± SEM. For some points, SEM is smaller than the symbol size and not visually discernible. Each data point represents an individual mouse as a biological replicate with similar results. The initial sample sizes per group were: Saline + Vehicle ( n = 7), AngII + Vehicle ( n = 13), AngII + Amlodipine ( n = 12), AngII + Nifedipine ( n = 12), AngII + Diltiazem ( n = 11), AngII + Verapamil ( n = 11). Due to mortality during the experimental period, exact n at each time point is provided in the Source Data file. Statistical analysis : Two-sided one-way ANOVA with Dunnett multiple comparisons test, Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test or Kruskal-Wallis test with Dunn’s multiple comparisons was used as appropriate for ( b-e , h , i ) at different time points (detailed for each comparison in the Source Data file). * P < 0.05 vs. AngII + Vehicle group. Exact P -values for all comparisons are provided in the Source Data file. Statistical analysis of ( k –m ) were performed using two-sided Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test. Source data are provided as a Source Data file. AngII angiotensin II, SBP systolic blood pressure, CCB calcium channel blocker, rd-PWV root to descending aorta pulse wave velocity.
    Noninvasive Tail Cuff Blood Pressure System Coda, supplied by Kent Scientific Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/coda+noninvasive+tail+cuff+blood+pressure+system/coda+non+invasive+blood+pressure+system/pmc12054525-60-10-15
    Average 90 stars, based on 1 article reviews
    noninvasive tail-cuff blood pressure system coda - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    86
    Kent Scientific Corp coda noninvasive tail cuff blood pressure system
    a Experiment design. 16-week-old C57BL/6 J mice were infused with AngII (1000 ng/kg·min − 1 ) for 28 days. After 7 days of infusion, the mice were daily injected with vehicle, dihydropyridine CCBs [amlodipine (1 mg/kg/day) or nifedipine (20 mg/kg/day)], benzothiazepine CCB [diltiazem (8 mg/kg/day)], phenylalkylamine CCBs [verapamil (12 mg/kg/day)]. b SBP was measured <t>by</t> <t>tail-cuff</t> at −7, 0, 3, 7, 14, 21 days after vehicle/CCBs treatment. c –e Ultrasound-monitored maximal inner diameters of the aortic root, ascending aorta, and aortic arch at 0, 7, 14, 21 days. f Representative ultrasound images of thoracic aorta after 21 days of vehicle/CCB treatment. g –i Monitoring of rd-PWV and ascending aortic strain in mice at different time points by M-mode ultrasound. ( g ) Schematic illustration of calculation method. ( h ) rd-PWV. i Ascending aortic strain. j Representative ex vivo morphology of thoracic aortas. Scale bar=2 mm. k –m Maximal external diameters of ascending aorta ( k ), aortic arch ( l ), and descending aorta ( m ). Data presentation : Data in ( b –e, h , i, k-m ) are presented as mean ± SEM. For some points, SEM is smaller than the symbol size and not visually discernible. Each data point represents an individual mouse as a biological replicate with similar results. The initial sample sizes per group were: Saline + Vehicle ( n = 7), AngII + Vehicle ( n = 13), AngII + Amlodipine ( n = 12), AngII + Nifedipine ( n = 12), AngII + Diltiazem ( n = 11), AngII + Verapamil ( n = 11). Due to mortality during the experimental period, exact n at each time point is provided in the Source Data file. Statistical analysis : Two-sided one-way ANOVA with Dunnett multiple comparisons test, Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test or Kruskal-Wallis test with Dunn’s multiple comparisons was used as appropriate for ( b-e , h , i ) at different time points (detailed for each comparison in the Source Data file). * P < 0.05 vs. AngII + Vehicle group. Exact P -values for all comparisons are provided in the Source Data file. Statistical analysis of ( k –m ) were performed using two-sided Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test. Source data are provided as a Source Data file. AngII angiotensin II, SBP systolic blood pressure, CCB calcium channel blocker, rd-PWV root to descending aorta pulse wave velocity.
    Coda Noninvasive Tail Cuff Blood Pressure System, supplied by Kent Scientific Corp, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/coda+noninvasive+tail+cuff+blood+pressure+system/coda+system/10__1016_slash_j__fbio__2024__105235-124-6-12
    Average 86 stars, based on 1 article reviews
    coda noninvasive tail cuff blood pressure system - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    90
    Kent Scientific Corp tail cuff coda noninvasive blood pressure system
    a Experiment design. 16-week-old C57BL/6 J mice were infused with AngII (1000 ng/kg·min − 1 ) for 28 days. After 7 days of infusion, the mice were daily injected with vehicle, dihydropyridine CCBs [amlodipine (1 mg/kg/day) or nifedipine (20 mg/kg/day)], benzothiazepine CCB [diltiazem (8 mg/kg/day)], phenylalkylamine CCBs [verapamil (12 mg/kg/day)]. b SBP was measured <t>by</t> <t>tail-cuff</t> at −7, 0, 3, 7, 14, 21 days after vehicle/CCBs treatment. c –e Ultrasound-monitored maximal inner diameters of the aortic root, ascending aorta, and aortic arch at 0, 7, 14, 21 days. f Representative ultrasound images of thoracic aorta after 21 days of vehicle/CCB treatment. g –i Monitoring of rd-PWV and ascending aortic strain in mice at different time points by M-mode ultrasound. ( g ) Schematic illustration of calculation method. ( h ) rd-PWV. i Ascending aortic strain. j Representative ex vivo morphology of thoracic aortas. Scale bar=2 mm. k –m Maximal external diameters of ascending aorta ( k ), aortic arch ( l ), and descending aorta ( m ). Data presentation : Data in ( b –e, h , i, k-m ) are presented as mean ± SEM. For some points, SEM is smaller than the symbol size and not visually discernible. Each data point represents an individual mouse as a biological replicate with similar results. The initial sample sizes per group were: Saline + Vehicle ( n = 7), AngII + Vehicle ( n = 13), AngII + Amlodipine ( n = 12), AngII + Nifedipine ( n = 12), AngII + Diltiazem ( n = 11), AngII + Verapamil ( n = 11). Due to mortality during the experimental period, exact n at each time point is provided in the Source Data file. Statistical analysis : Two-sided one-way ANOVA with Dunnett multiple comparisons test, Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test or Kruskal-Wallis test with Dunn’s multiple comparisons was used as appropriate for ( b-e , h , i ) at different time points (detailed for each comparison in the Source Data file). * P < 0.05 vs. AngII + Vehicle group. Exact P -values for all comparisons are provided in the Source Data file. Statistical analysis of ( k –m ) were performed using two-sided Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test. Source data are provided as a Source Data file. AngII angiotensin II, SBP systolic blood pressure, CCB calcium channel blocker, rd-PWV root to descending aorta pulse wave velocity.
    Tail Cuff Coda Noninvasive Blood Pressure System, supplied by Kent Scientific Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/coda+noninvasive+tail+cuff+blood+pressure+system/coda+non+invasive+blood+pressure+system/pmc11361356__cir___150___770___s001-249-10-19
    Average 90 stars, based on 1 article reviews
    tail cuff coda noninvasive blood pressure system - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Kent Scientific Corp coda noninvasive tail-cuff blood pressure system
    a Experiment design. 16-week-old C57BL/6 J mice were infused with AngII (1000 ng/kg·min − 1 ) for 28 days. After 7 days of infusion, the mice were daily injected with vehicle, dihydropyridine CCBs [amlodipine (1 mg/kg/day) or nifedipine (20 mg/kg/day)], benzothiazepine CCB [diltiazem (8 mg/kg/day)], phenylalkylamine CCBs [verapamil (12 mg/kg/day)]. b SBP was measured <t>by</t> <t>tail-cuff</t> at −7, 0, 3, 7, 14, 21 days after vehicle/CCBs treatment. c –e Ultrasound-monitored maximal inner diameters of the aortic root, ascending aorta, and aortic arch at 0, 7, 14, 21 days. f Representative ultrasound images of thoracic aorta after 21 days of vehicle/CCB treatment. g –i Monitoring of rd-PWV and ascending aortic strain in mice at different time points by M-mode ultrasound. ( g ) Schematic illustration of calculation method. ( h ) rd-PWV. i Ascending aortic strain. j Representative ex vivo morphology of thoracic aortas. Scale bar=2 mm. k –m Maximal external diameters of ascending aorta ( k ), aortic arch ( l ), and descending aorta ( m ). Data presentation : Data in ( b –e, h , i, k-m ) are presented as mean ± SEM. For some points, SEM is smaller than the symbol size and not visually discernible. Each data point represents an individual mouse as a biological replicate with similar results. The initial sample sizes per group were: Saline + Vehicle ( n = 7), AngII + Vehicle ( n = 13), AngII + Amlodipine ( n = 12), AngII + Nifedipine ( n = 12), AngII + Diltiazem ( n = 11), AngII + Verapamil ( n = 11). Due to mortality during the experimental period, exact n at each time point is provided in the Source Data file. Statistical analysis : Two-sided one-way ANOVA with Dunnett multiple comparisons test, Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test or Kruskal-Wallis test with Dunn’s multiple comparisons was used as appropriate for ( b-e , h , i ) at different time points (detailed for each comparison in the Source Data file). * P < 0.05 vs. AngII + Vehicle group. Exact P -values for all comparisons are provided in the Source Data file. Statistical analysis of ( k –m ) were performed using two-sided Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test. Source data are provided as a Source Data file. AngII angiotensin II, SBP systolic blood pressure, CCB calcium channel blocker, rd-PWV root to descending aorta pulse wave velocity.
    Coda Noninvasive Tail Cuff Blood Pressure System, supplied by Kent Scientific Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/coda+noninvasive+tail+cuff+blood+pressure+system/coda+non+invasive+blood+pressure+system/pmc11157504-155-11-17
    Average 90 stars, based on 1 article reviews
    coda noninvasive tail-cuff blood pressure system - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Kent Scientific Corp noninvasive tail‐cuff blood pressure system (coda monitor
    a Experiment design. 16-week-old C57BL/6 J mice were infused with AngII (1000 ng/kg·min − 1 ) for 28 days. After 7 days of infusion, the mice were daily injected with vehicle, dihydropyridine CCBs [amlodipine (1 mg/kg/day) or nifedipine (20 mg/kg/day)], benzothiazepine CCB [diltiazem (8 mg/kg/day)], phenylalkylamine CCBs [verapamil (12 mg/kg/day)]. b SBP was measured <t>by</t> <t>tail-cuff</t> at −7, 0, 3, 7, 14, 21 days after vehicle/CCBs treatment. c –e Ultrasound-monitored maximal inner diameters of the aortic root, ascending aorta, and aortic arch at 0, 7, 14, 21 days. f Representative ultrasound images of thoracic aorta after 21 days of vehicle/CCB treatment. g –i Monitoring of rd-PWV and ascending aortic strain in mice at different time points by M-mode ultrasound. ( g ) Schematic illustration of calculation method. ( h ) rd-PWV. i Ascending aortic strain. j Representative ex vivo morphology of thoracic aortas. Scale bar=2 mm. k –m Maximal external diameters of ascending aorta ( k ), aortic arch ( l ), and descending aorta ( m ). Data presentation : Data in ( b –e, h , i, k-m ) are presented as mean ± SEM. For some points, SEM is smaller than the symbol size and not visually discernible. Each data point represents an individual mouse as a biological replicate with similar results. The initial sample sizes per group were: Saline + Vehicle ( n = 7), AngII + Vehicle ( n = 13), AngII + Amlodipine ( n = 12), AngII + Nifedipine ( n = 12), AngII + Diltiazem ( n = 11), AngII + Verapamil ( n = 11). Due to mortality during the experimental period, exact n at each time point is provided in the Source Data file. Statistical analysis : Two-sided one-way ANOVA with Dunnett multiple comparisons test, Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test or Kruskal-Wallis test with Dunn’s multiple comparisons was used as appropriate for ( b-e , h , i ) at different time points (detailed for each comparison in the Source Data file). * P < 0.05 vs. AngII + Vehicle group. Exact P -values for all comparisons are provided in the Source Data file. Statistical analysis of ( k –m ) were performed using two-sided Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test. Source data are provided as a Source Data file. AngII angiotensin II, SBP systolic blood pressure, CCB calcium channel blocker, rd-PWV root to descending aorta pulse wave velocity.
    Noninvasive Tail‐Cuff Blood Pressure System (Coda Monitor, supplied by Kent Scientific Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/coda+noninvasive+tail+cuff+blood+pressure+system/computerized+tail+cuff+blood+pressure+system/pmc11234435-239-7-13
    Average 90 stars, based on 1 article reviews
    noninvasive tail‐cuff blood pressure system (coda monitor - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    a Experiment design. 16-week-old C57BL/6 J mice were infused with AngII (1000 ng/kg·min − 1 ) for 28 days. After 7 days of infusion, the mice were daily injected with vehicle, dihydropyridine CCBs [amlodipine (1 mg/kg/day) or nifedipine (20 mg/kg/day)], benzothiazepine CCB [diltiazem (8 mg/kg/day)], phenylalkylamine CCBs [verapamil (12 mg/kg/day)]. b SBP was measured by tail-cuff at −7, 0, 3, 7, 14, 21 days after vehicle/CCBs treatment. c –e Ultrasound-monitored maximal inner diameters of the aortic root, ascending aorta, and aortic arch at 0, 7, 14, 21 days. f Representative ultrasound images of thoracic aorta after 21 days of vehicle/CCB treatment. g –i Monitoring of rd-PWV and ascending aortic strain in mice at different time points by M-mode ultrasound. ( g ) Schematic illustration of calculation method. ( h ) rd-PWV. i Ascending aortic strain. j Representative ex vivo morphology of thoracic aortas. Scale bar=2 mm. k –m Maximal external diameters of ascending aorta ( k ), aortic arch ( l ), and descending aorta ( m ). Data presentation : Data in ( b –e, h , i, k-m ) are presented as mean ± SEM. For some points, SEM is smaller than the symbol size and not visually discernible. Each data point represents an individual mouse as a biological replicate with similar results. The initial sample sizes per group were: Saline + Vehicle ( n = 7), AngII + Vehicle ( n = 13), AngII + Amlodipine ( n = 12), AngII + Nifedipine ( n = 12), AngII + Diltiazem ( n = 11), AngII + Verapamil ( n = 11). Due to mortality during the experimental period, exact n at each time point is provided in the Source Data file. Statistical analysis : Two-sided one-way ANOVA with Dunnett multiple comparisons test, Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test or Kruskal-Wallis test with Dunn’s multiple comparisons was used as appropriate for ( b-e , h , i ) at different time points (detailed for each comparison in the Source Data file). * P < 0.05 vs. AngII + Vehicle group. Exact P -values for all comparisons are provided in the Source Data file. Statistical analysis of ( k –m ) were performed using two-sided Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test. Source data are provided as a Source Data file. AngII angiotensin II, SBP systolic blood pressure, CCB calcium channel blocker, rd-PWV root to descending aorta pulse wave velocity.

    Journal: Nature Communications

    Article Title: Calcium channel blockers increase the risk of aortic aneurysm and dissection

    doi: 10.1038/s41467-025-68086-5

    Figure Lengend Snippet: a Experiment design. 16-week-old C57BL/6 J mice were infused with AngII (1000 ng/kg·min − 1 ) for 28 days. After 7 days of infusion, the mice were daily injected with vehicle, dihydropyridine CCBs [amlodipine (1 mg/kg/day) or nifedipine (20 mg/kg/day)], benzothiazepine CCB [diltiazem (8 mg/kg/day)], phenylalkylamine CCBs [verapamil (12 mg/kg/day)]. b SBP was measured by tail-cuff at −7, 0, 3, 7, 14, 21 days after vehicle/CCBs treatment. c –e Ultrasound-monitored maximal inner diameters of the aortic root, ascending aorta, and aortic arch at 0, 7, 14, 21 days. f Representative ultrasound images of thoracic aorta after 21 days of vehicle/CCB treatment. g –i Monitoring of rd-PWV and ascending aortic strain in mice at different time points by M-mode ultrasound. ( g ) Schematic illustration of calculation method. ( h ) rd-PWV. i Ascending aortic strain. j Representative ex vivo morphology of thoracic aortas. Scale bar=2 mm. k –m Maximal external diameters of ascending aorta ( k ), aortic arch ( l ), and descending aorta ( m ). Data presentation : Data in ( b –e, h , i, k-m ) are presented as mean ± SEM. For some points, SEM is smaller than the symbol size and not visually discernible. Each data point represents an individual mouse as a biological replicate with similar results. The initial sample sizes per group were: Saline + Vehicle ( n = 7), AngII + Vehicle ( n = 13), AngII + Amlodipine ( n = 12), AngII + Nifedipine ( n = 12), AngII + Diltiazem ( n = 11), AngII + Verapamil ( n = 11). Due to mortality during the experimental period, exact n at each time point is provided in the Source Data file. Statistical analysis : Two-sided one-way ANOVA with Dunnett multiple comparisons test, Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test or Kruskal-Wallis test with Dunn’s multiple comparisons was used as appropriate for ( b-e , h , i ) at different time points (detailed for each comparison in the Source Data file). * P < 0.05 vs. AngII + Vehicle group. Exact P -values for all comparisons are provided in the Source Data file. Statistical analysis of ( k –m ) were performed using two-sided Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test. Source data are provided as a Source Data file. AngII angiotensin II, SBP systolic blood pressure, CCB calcium channel blocker, rd-PWV root to descending aorta pulse wave velocity.

    Article Snippet: Briefly, a noninvasive computerized CODA tail-cuff blood pressure system (Kent Scientific, Torrington, CT, USA) was used to measure mouse SBP.

    Techniques: Injection, Ex Vivo, Saline, Comparison

    a Experiment design. 8-week-old mice infrarenal abdominal aortas were incubated with PBS or elastase (10 mg/ml) and then daily injected with vehicle, amlodipine (1 mg/kg/day), nifedipine (20 mg/kg/day), diltiazem (8 mg/kg/day) or verapamil (12 mg/kg/day) for 14 days. b SBP was measured by tail-cuff at 14 days after vehicle/CCBs treatment. c Representative ex vivo morphology of aortas. Scale bar=2 mm. d Maximal external diameter of abdominal aorta. e , f Representative image of abdominal aorta elastin Van Gieson staining ( e ) and statistical analysis on elastin degradation grade. Scale bar=250/50 μm. Data presentation: Data in ( b , d , e , f ) are presented as mean ± SEM. Each data point represents an individual mouse as a biological replicate with similar results. The sample sizes per group were: PBS + vehicle ( n = 3), Elastase + vehicle ( n = 9), Elastase + amlodipine ( n = 11), Elastase + nifedipine ( n = 10), Elastase + diltiazem ( n = 12), Elastase + verapamil ( n = 9). Statistical analysis: Statistical analysis of ( b ) were performed using two-sided one-way ANOVA with Dunnett multiple comparisons test. Statistical analysis of ( d ) were performed using two-sided Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test. Statistical analysis of ( f ) were performed using two-sided Kruskal-Wallis test with Dunn’s multiple comparisons. Source data are provided as a Source Data file. CCB calcium channel blocker, PBS phosphate buffered saline, SBP systolic blood pressure.

    Journal: Nature Communications

    Article Title: Calcium channel blockers increase the risk of aortic aneurysm and dissection

    doi: 10.1038/s41467-025-68086-5

    Figure Lengend Snippet: a Experiment design. 8-week-old mice infrarenal abdominal aortas were incubated with PBS or elastase (10 mg/ml) and then daily injected with vehicle, amlodipine (1 mg/kg/day), nifedipine (20 mg/kg/day), diltiazem (8 mg/kg/day) or verapamil (12 mg/kg/day) for 14 days. b SBP was measured by tail-cuff at 14 days after vehicle/CCBs treatment. c Representative ex vivo morphology of aortas. Scale bar=2 mm. d Maximal external diameter of abdominal aorta. e , f Representative image of abdominal aorta elastin Van Gieson staining ( e ) and statistical analysis on elastin degradation grade. Scale bar=250/50 μm. Data presentation: Data in ( b , d , e , f ) are presented as mean ± SEM. Each data point represents an individual mouse as a biological replicate with similar results. The sample sizes per group were: PBS + vehicle ( n = 3), Elastase + vehicle ( n = 9), Elastase + amlodipine ( n = 11), Elastase + nifedipine ( n = 10), Elastase + diltiazem ( n = 12), Elastase + verapamil ( n = 9). Statistical analysis: Statistical analysis of ( b ) were performed using two-sided one-way ANOVA with Dunnett multiple comparisons test. Statistical analysis of ( d ) were performed using two-sided Brown-Forsythe and Welch ANOVA with Dunnett T3 multiple comparisons test. Statistical analysis of ( f ) were performed using two-sided Kruskal-Wallis test with Dunn’s multiple comparisons. Source data are provided as a Source Data file. CCB calcium channel blocker, PBS phosphate buffered saline, SBP systolic blood pressure.

    Article Snippet: Briefly, a noninvasive computerized CODA tail-cuff blood pressure system (Kent Scientific, Torrington, CT, USA) was used to measure mouse SBP.

    Techniques: Incubation, Injection, Ex Vivo, Staining, Saline